Regeneus Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other
pharmaceutical manufacturers in Australasia:
ECS Botanics Holdings Ltd
(2019
sales of 1,384.00 Australian Dollars [US$949.89 ]
),
Genetic Technologies Limited
(25,444.00 Australian Dollars [US$17,463.23 ]
of which 100%
was Operations), and
Prescient Therapeutics Ltd
(72,109.00 Australian Dollars [US$49,491.29 ]
).
Sales Analysis.
Sales fell dramatically in 2019:
Regeneus Ltd reported sales of A$25,077.00 (US$17.21 thousand)
for the
fiscal
year ending
June of 2019.
This
represents
a
sharp
decrease of 95.9%
versus 2018, when the company's sales were A$610,511.00 .